GLP-1 Receptor Agonists and Psychiatric Outcomes in Adolescents
GLP-1 drugs show no increased psychiatric risk in adolescents and may actually lower suicidal ideation, easing concerns for teens with obesity or diabetes.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
A specific stem cell program and CD112 immunological axis…
Blocking specific immune checkpoints restores natural killer cells' ability to attack a deadly leukemia subtype in lab tests, opening a targeted treatment path.
Promising but preliminaryMulti-omics profiling reveals tumor microenvironment characteristics…
Blocking a tumor-signaling protein restored immune cell function and boosted immunotherapy effectiveness in resistant lung cancer models.
Near-term implementable findingAssociation Between SGLT2 Inhibitors and DPP-4 Inhibitors Use and…
Large Korean health data confirm two common diabetes medications don't increase pancreatitis risk, supporting their safe continued use.
Underserved or high-risk populationsVariation in stroke survivors' long-term home care use
Long-term stroke survivor data reveal gaps in home care access for certain groups, highlighting where community support policies need strengthening.